BML Capital Management, LLC - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 24 filers reported holding ARCA BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
BML Capital Management, LLC ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,420,929
-1.0%
706,9300.0%1.30%
+1.1%
Q2 2023$1,435,068
+2.0%
706,9300.0%1.29%
+6.2%
Q1 2023$1,406,791
-30.8%
706,930
-17.6%
1.22%
-37.4%
Q4 2022$2,034,067858,2561.94%
Other shareholders
ARCA BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 706,930$1,406,7911.22%
Newtyn Management, LLC 519,765$1,034,3320.20%
Murchinson Ltd. 52,800$100,6800.01%
Marquette Asset Management, LLC 17,318$34,4630.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$93,4270.00%
Tekla Capital Management LLC 32,461$64,5970.00%
OSAIC HOLDINGS, INC. 57$1130.00%
DIMENSIONAL FUND ADVISORS LP 42,502$84,5790.00%
Parallel Advisors, LLC 244$4860.00%
BANK OF AMERICA CORP /DE/ 31$620.00%
View complete list of ARCA BIOPHARMA INC shareholders